According to Biolase 's latest financial reports the company's current EPS (TTM) is -232,48 โฌ. In 2022 the company made an earnings per share (EPS) of -360,63 โฌ a decrease over its 2021 EPS that were of -234,71 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -255,96 โฌ | -29.03% |
2022 | -360,63 โฌ | 53.65% |
2021 | -234,71 โฌ | -81.87% |
2020 | -1.294 โฌ | -25.32% |
2019 | -1.733 โฌ | -24.76% |
2018 | -2.303 โฌ | -26.06% |
2017 | -3.115 โฌ | 4.33% |
2016 | -2.986 โฌ | -14.71% |
2015 | -3.501 โฌ | -26.09% |
2014 | -4.736 โฌ | 35.41% |
2013 | -3.498 โฌ | 244.31% |
2012 | -1.016 โฌ | -38.05% |
2011 | -1.640 โฌ | -64.8% |
2010 | -4.658 โฌ | 347.66% |
2009 | -1.041 โฌ | -71.05% |
2008 | -3.595 โฌ | 22.58% |
2007 | -2.933 โฌ | 55% |
2006 | -1.892 โฌ | -74.03% |
2005 | -7.284 โฌ | -22.22% |
2004 | -9.366 โฌ | -208.79% |
2003 | 8.609 โฌ | 1720% |
2002 | 473,01 โฌ | -171.43% |
2001 | -662,22 โฌ | -65% |
2000 | -1.892 โฌ | -25.62% |
1999 | -2.544 โฌ | -56.92% |
1998 | -5.905 โฌ | 209.52% |
1997 | -1.908 โฌ | 5% |
1996 | -1.817 โฌ |